DMQ Clinical Trial Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
What is DMQ Clinical Trial?
The randomized, multi-center, international STAR trial will compare active treatment with Zenvia 30/10 mg (DM/Q) and Zenvia 20/10 mg (DM/Q) to placebo during a three-month, double-blinded phase, followed by a three-month, open-label extension study to assess changes in crying/laughing episode rates.
Read more...
Reasons Taken
2 patients in the community are taking or have taken DMQ Clinical Trial.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Emotional lability | 2 | 100% |
Dosages
Based on the patients currently taking DMQ Clinical Trial.
| 30 mg day | ||
|---|---|---|
1
|
||
Duration
How long current patients have been taking DMQ Clinical Trial or how long patients were taking DMQ Clinical Trial before stopping.
Currently taking DMQ Clinical Trial
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Stopped taking DMQ Clinical Trial
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 1 | 100% |  |